چهارشنبه 26 دی 1403
[Archive]
دوره 6، شماره 3 - ( 4-1387 )
جلد 6 شماره 3 صفحات 0-83 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ezechi O C, Loto O M, Ezeobi P M, Okogbo F O, Gbajabiamila T, Nwokoro C A. Safety and efficacy of misoprostol in induction of labour in prelabour rupture of fetal membrane in Nigerian women: a multicenter study. IJRM 2008; 6 (3) :83-0
URL: http://ijrm.ir/article-1-106-fa.html
URL: http://ijrm.ir/article-1-106-fa.html
Safety and efficacy of misoprostol in induction of labour in prelabour rupture of fetal membrane in Nigerian women: a multicenter study. International Journal of Reproductive BioMedicine. 1387; 6 (3) :83-0
چکیده: (2287 مشاهده)
Background: Misoprostol, a prostaglandin E1 analogue compared to prostaglandin E2, has the advantage of being inexpensive and stable at room temperature, with its proven efficacy and safety. However studies on the effect of pH on the efficacy of misoprostol have yielded conflicting results. Thus its use in the induction of labour in patients with premature rupture of membrane requires further investigation.
Objective: To evaluate the safety and efficacy of misoprostol in induction of labour in Nigerian women with prelabour rupture of membrane after 34 weeks of gestation.
Materials and Methods: Three hundred and forty six Nigerian women with prelabour rupture of membrane who consented to participate in the trial were randomised into two arms of misoprostol and oxytocin. Labour was managed with WHO partograph. The primary outcome was the caesarean section rate and induction vaginal delivery interval.
Results: The mean induction to vaginal delivery interval was significantly shorter in the misoprostol arm (504 mins) compared to 627 mins in the oxytocin arm (t=3.97; p=0.005). The caesarean section rate of 18.1% among the misoprostol arm was also significantly lower than the 41.4% recorded in the oxytocin arm (p=0.002). Among patients with Bishop score greater than 6 there were no statistically significant differences between the two groups in the outcomes measured.
Conclusion: Misoprostol is not only effective but also safe when compared with titrated oxytocin in Nigerian parturients with prelabour rupture of membrane after 34 weeks.
Objective: To evaluate the safety and efficacy of misoprostol in induction of labour in Nigerian women with prelabour rupture of membrane after 34 weeks of gestation.
Materials and Methods: Three hundred and forty six Nigerian women with prelabour rupture of membrane who consented to participate in the trial were randomised into two arms of misoprostol and oxytocin. Labour was managed with WHO partograph. The primary outcome was the caesarean section rate and induction vaginal delivery interval.
Results: The mean induction to vaginal delivery interval was significantly shorter in the misoprostol arm (504 mins) compared to 627 mins in the oxytocin arm (t=3.97; p=0.005). The caesarean section rate of 18.1% among the misoprostol arm was also significantly lower than the 41.4% recorded in the oxytocin arm (p=0.002). Among patients with Bishop score greater than 6 there were no statistically significant differences between the two groups in the outcomes measured.
Conclusion: Misoprostol is not only effective but also safe when compared with titrated oxytocin in Nigerian parturients with prelabour rupture of membrane after 34 weeks.
نوع مطالعه: Original Article |
فهرست منابع
1. Dare FO, Ademowore AS, Ogunniyi S. Experience with 159 cases of premature rupture of membrane in Ile- Ife Nigeria. Tropical Doctor 1989; 19: 160-162. [DOI:10.1177/004947558901900406]
2. Wennstrom KD, Weiner CP. Premature rupture of membrane. Clinics of North America 1992; 19: 247-251.
3. Dare FO, Bako AU, Ezechi OC. Puerperal sepsis: a preventable postpartum complication. Trop Doct 1998; 28: 92-95. [DOI:10.1177/004947559802800212]
4. Duff P, Huff RW, Gibbs RS. Management of premature rupture of membranes and unfavourable cervix in term pregnancy. Obstet Gynecol 1984; 63: 697-702.
5. Kappy Ka, Centriole CL, Kuppel RA, Ingardia CJ, Sbarra AJ, Scerbo JC, et al. Premature rupture of fetal membranes at term: comparism of induced and spontaneous labours. Journal of Reproductive medicine 1982; 27: 29-33.
6. Remington Js, Klein JO. Infectious disease of the infant and the newborn infant. 3rd ed. Philadelphia: WB Saunders; 1990; 610-612.
7. Kwawukume EY, Ayertey RP. The use of misoprostol for induction of labour in a low resource setting. Trop J Obstetric and Gynaecology 2002; 19: 78-81.
8. Fawole Ao, Adegbola O, Adeyemi AS, Oladapo OT, Alao MO. Misoprostol for induction of labour. A survey of attitude. Arch Gynecol Obstet 2008; 19 [Epub ahead of print]. [DOI:10.1007/s00404-008-0584-9]
9. Gunlap S, Bildirici I. The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of labor. Acta Obstet Gynaecol Scanda 2000; 79:283-285. [DOI:10.1034/j.1600-0412.2000.079004283.x]
10. Ramsey PS, Ogburn Pl Jr, Harris DY, Heise RH, Ramin KD. Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labour induction. Am J Obstet Gynecol 2000; 182: 1616-1619. [DOI:10.1067/mob.2000.107441]
11. Li XM, Wan J, Xu CF, Zhang Y, Fang L, Shi ZJ, et al. Misoprostol in labour induction of term pregnancy.A Meta analysis. China Medical Journal (English) 2004 ; 117 : 449- 452.
12. Von Hertzen H, Piaggio G, Houng N, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. The lancet 2008; 369: 1938-1946. [DOI:10.1016/S0140-6736(07)60914-3]
13. World Health Organisation (WHO). Preventing prolonged labour: a practical guide-the partograph. 1994; WHO/FHE/MSM/93.8, 93.9. 93.10, 93.11.
14. Chang YK, Chen WH, Yu MH, Liu HS. Intracervical misoprostol and prostaglandin E2 for labour induction. IJGO 2003; 80: 23-28. [DOI:10.1016/S0020-7292(02)00333-8]
15. Sanchez-Ramos L, Kauntiz AM, Del Valle GO, Delke , Schroeder PA, Briones DK. Labour induction with prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomised trial. Obstet Gynecol 1993; 81: 332-336. [DOI:10.1016/0020-7292(93)90338-W]
16. Kramer RL, Gilson GJ, Morrison DS, Martin D, Gonzales JL, Qualls CR. A randomised trial of misoprostol and oxytocin for induction of labour: safety and efficacy. Obstet Gynecol 1997; 89: 387-391. [DOI:10.1016/S0029-7844(97)00363-3]
17. Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparism of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labour induction. Am J Obstet Gynecol 1995; 172: 1804-1810. [DOI:10.1016/0002-9378(95)91415-3]
18. Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labour induction with term premature rupture of membranes: a Meta analysis. Obstetrics and Gynecology. Obstet Gynecol 2005; 106: 593-601. [DOI:10.1097/01.AOG.0000172425.56840.57]
19. Wing DA, Rahall A, Jones MM, Goodwin TM, Paul RH. Misoprostol: an effective agent for cervical ripening and labour-inducing agents. Obstet Gynecol 1997; 89: 633-642. [DOI:10.1016/S0029-7844(96)00374-2]
20. Windrim R, Bennett K, Mundle W, Young DC. Oral administration of misoprostol for labour induction: a randomised controlled trial. Obstet Gynecol 1997; 89: 392-397. [DOI:10.1016/S0029-7844(96)00523-6]
21. Cheng SY, Ming H, Lee JC. Titrated oral compared with vaginal misoprostol for labour induction: a randomised controlled trial. Obstetrics and Gynecology 2008; 111: 119-125. [DOI:10.1097/01.AOG.0000297313.68644.71]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
